SlideShare a Scribd company logo
1 of 1
Characterization of Lipid Based spherulites
The lipid spherulitic phase identified was the preferred state for proprietary formulation for
suspending insoluble drugs. An assay was performed to complement this formulation studies to
determine forwhich formulationsthe spherulitic phase is present and if lipid phase analysis can be
used to determine drug suspension behaviour. Also, samples were investigated for the effect of
additional ingredients on the formulations ability to suspend pharmaceuticals. The formulations
were quick, simple and safe to manufacture.
Abstract –
Structuredsurfactantsare lipidbasedspheruliticsystems that are formed by low- shearing which is
formulatedforsuspendingdrug.Thisstudyinvolvesthe characterizationof spherulitestodetermine
theirstructure,shape,size,numberandalsothe yieldpointtosuspendin-soluble drugbythe means
of optical microscopy,dynamiclight scattering and rheological studies. The lipid based spherulites
were identified as onion ring structures under bright field microscopy and these crystals visible
structuresundercrosspolarisationmicroscopy which displays a birefringent property. The number
of spherulites per millilitre of the suspension was also counted by haemocytometer. The size of
these spheruliteswasdeterminedusingagraticule andwere approximately 1-2 microns in size. The
sizesof these structures were compared with the results obtained by the dynamic light scattering;
where the size rangedfrom1-2 microns.Subsequently,rheologicalparametersuchasgeometry was
chosenbasedonthe size of the spherulites.The suspensionwasdilutedinordertomake it pourable
withhighyieldpointandshearthinningproperties.The geometry used was cone and plate and was
compared with concentric cylinders. It was found that 16% w/w is required in order to make the
suspension pourable and this dilution was selected to suspend acetaminophen. Rheology for the
suspension with the drug was performed that resulted in high yield point at 1/s shear rate. The
stability of these suspensions was analysed by centrifuging the sample at varying speeds.

More Related Content

What's hot

MansiShah-PDT2013
MansiShah-PDT2013MansiShah-PDT2013
MansiShah-PDT2013
Mansi Shah
 
Biotechnology Poster Session. William Lien
Biotechnology Poster Session. William LienBiotechnology Poster Session. William Lien
Biotechnology Poster Session. William Lien
William Lien
 
Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
Arpan Dhungel
 
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
ijpsmjournal
 

What's hot (16)

ISOFLAVONES and ERECTILE DYSFUNCTION: is PDE5 the link?
ISOFLAVONES and ERECTILE DYSFUNCTION: is PDE5 the link? ISOFLAVONES and ERECTILE DYSFUNCTION: is PDE5 the link?
ISOFLAVONES and ERECTILE DYSFUNCTION: is PDE5 the link?
 
MansiShah-PDT2013
MansiShah-PDT2013MansiShah-PDT2013
MansiShah-PDT2013
 
Stability aspects of liposomes
Stability aspects of liposomesStability aspects of liposomes
Stability aspects of liposomes
 
Multiparticulate drug delivery systems
Multiparticulate drug delivery systemsMultiparticulate drug delivery systems
Multiparticulate drug delivery systems
 
Biotechnology Poster Session. William Lien
Biotechnology Poster Session. William LienBiotechnology Poster Session. William Lien
Biotechnology Poster Session. William Lien
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)
 
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of CarvedilolFormulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
 
latest regulatory guidelines (1) Final.pptx
latest regulatory guidelines (1) Final.pptxlatest regulatory guidelines (1) Final.pptx
latest regulatory guidelines (1) Final.pptx
 
Formulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptxFormulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptx
 
Liquisolid technology
Liquisolid technologyLiquisolid technology
Liquisolid technology
 
Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
 
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility...
 
RESEALED ERYTHROCYTES AS DRUG DELIVERY SYSTEM
RESEALED ERYTHROCYTES AS DRUG DELIVERY SYSTEMRESEALED ERYTHROCYTES AS DRUG DELIVERY SYSTEM
RESEALED ERYTHROCYTES AS DRUG DELIVERY SYSTEM
 
An Updates on veternary formulations.pptx
An Updates on veternary formulations.pptxAn Updates on veternary formulations.pptx
An Updates on veternary formulations.pptx
 
Application of preformulation_consideration_in_the_development_of
Application of preformulation_consideration_in_the_development_ofApplication of preformulation_consideration_in_the_development_of
Application of preformulation_consideration_in_the_development_of
 
Pharmacosomes
PharmacosomesPharmacosomes
Pharmacosomes
 

Similar to Abstarct

Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
ijtsrd
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oral
Patel Parth
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
Patel Parth
 

Similar to Abstarct (20)

Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
Formulation Development and Evaluation of Self Nano Emulsifying Drug Delivery...
 
Liposomes drug delivery systems
Liposomes drug delivery systemsLiposomes drug delivery systems
Liposomes drug delivery systems
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oral
 
IJPBA_2061_23_20230715_V1.pdf
IJPBA_2061_23_20230715_V1.pdfIJPBA_2061_23_20230715_V1.pdf
IJPBA_2061_23_20230715_V1.pdf
 
IJPBA_2061_23_20230715_V1.pdf
IJPBA_2061_23_20230715_V1.pdfIJPBA_2061_23_20230715_V1.pdf
IJPBA_2061_23_20230715_V1.pdf
 
PREFORMULATION.pptx
PREFORMULATION.pptxPREFORMULATION.pptx
PREFORMULATION.pptx
 
Solid lipid nanoparticles
Solid lipid nanoparticlesSolid lipid nanoparticles
Solid lipid nanoparticles
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
 
Liposomal formulation by factorial design approach By Pranav Lendhey
Liposomal formulation by factorial design approach By Pranav Lendhey Liposomal formulation by factorial design approach By Pranav Lendhey
Liposomal formulation by factorial design approach By Pranav Lendhey
 
Nano particle by Dhrestha Shrestha
Nano particle by Dhrestha ShresthaNano particle by Dhrestha Shrestha
Nano particle by Dhrestha Shrestha
 
preformulation studies
preformulation studiespreformulation studies
preformulation studies
 
Preformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drugPreformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drug
 
Spherical crystallization PPT.pptx
Spherical  crystallization PPT.pptxSpherical  crystallization PPT.pptx
Spherical crystallization PPT.pptx
 
Pharmacosomes
PharmacosomesPharmacosomes
Pharmacosomes
 
liposomes.pptx
liposomes.pptxliposomes.pptx
liposomes.pptx
 
DRUG PRODUCT PERFORMANCE, IN VITRO
DRUG PRODUCT PERFORMANCE, IN VITRODRUG PRODUCT PERFORMANCE, IN VITRO
DRUG PRODUCT PERFORMANCE, IN VITRO
 
Solid Lipid Nanopaticles
Solid Lipid NanopaticlesSolid Lipid Nanopaticles
Solid Lipid Nanopaticles
 
Preformulation
PreformulationPreformulation
Preformulation
 
pharmacosome
pharmacosomepharmacosome
pharmacosome
 
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxPREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
 

Abstarct

  • 1. Characterization of Lipid Based spherulites The lipid spherulitic phase identified was the preferred state for proprietary formulation for suspending insoluble drugs. An assay was performed to complement this formulation studies to determine forwhich formulationsthe spherulitic phase is present and if lipid phase analysis can be used to determine drug suspension behaviour. Also, samples were investigated for the effect of additional ingredients on the formulations ability to suspend pharmaceuticals. The formulations were quick, simple and safe to manufacture. Abstract – Structuredsurfactantsare lipidbasedspheruliticsystems that are formed by low- shearing which is formulatedforsuspendingdrug.Thisstudyinvolvesthe characterizationof spherulitestodetermine theirstructure,shape,size,numberandalsothe yieldpointtosuspendin-soluble drugbythe means of optical microscopy,dynamiclight scattering and rheological studies. The lipid based spherulites were identified as onion ring structures under bright field microscopy and these crystals visible structuresundercrosspolarisationmicroscopy which displays a birefringent property. The number of spherulites per millilitre of the suspension was also counted by haemocytometer. The size of these spheruliteswasdeterminedusingagraticule andwere approximately 1-2 microns in size. The sizesof these structures were compared with the results obtained by the dynamic light scattering; where the size rangedfrom1-2 microns.Subsequently,rheologicalparametersuchasgeometry was chosenbasedonthe size of the spherulites.The suspensionwasdilutedinordertomake it pourable withhighyieldpointandshearthinningproperties.The geometry used was cone and plate and was compared with concentric cylinders. It was found that 16% w/w is required in order to make the suspension pourable and this dilution was selected to suspend acetaminophen. Rheology for the suspension with the drug was performed that resulted in high yield point at 1/s shear rate. The stability of these suspensions was analysed by centrifuging the sample at varying speeds.